M L23 (Lisinopril 5 mg)
Pill with imprint M L23 is Orange, Round and has been identified as Lisinopril 5 mg. It is supplied by Mylan Pharmaceuticals Inc.
Lisinopril is used in the treatment of diabetic kidney disease; heart attack; high blood pressure; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Lisinopril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for M L23
Lisinopril
- Imprint
- M L23
- Strength
- 5 mg
- Color
- Orange
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
calcium phosphate dihydrate dibasic,
magnesium stearate,
mannitol,
povidone,
corn starch,
sodium lauryl sulfate,
FD&C Yellow No. 6
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 00378-2073 (Discontinued) | Mylan Pharmaceuticals Inc. |
| 51079-0981 (Discontinued) | UDL Laboratories Inc. |
| 63874-0558 (Discontinued) | Altura Pharmaceuticals Inc. (repackager) |
Related images for "M L23"
More about lisinopril
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (595)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: Angiotensin Converting Enzyme Inhibitors
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.